Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis to Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04150731
What this trial is testing

16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer

Who this might be right for
Breast Cancer
University of Aarhus 8
Not applicableStudy completedNCT07386639
What this trial is testing

Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver CancerNeoplasm Metastasis
Tongji University 19,019
Early research (Phase 1)Study completedNCT00695201
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 52
Not applicableLooking for participantsNCT04075305
What this trial is testing

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Who this might be right for
OncologyBreast CancerProstate Cancer+35 more
UMC Utrecht 8,000
Not applicableLooking for participantsNCT07727759
What this trial is testing

CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure

Who this might be right for
Post-Hepatectomy Liver FailureLiver FailureLiver Neoplasms+4 more
Minia University 1,070
Not applicableStudy completedNCT04090645
What this trial is testing

TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer

Who this might be right for
Liver, Cancer of, Non-Resectable
Methodist Health System 187
Not applicableEnded earlyNCT02787954
What this trial is testing

Prospective Tumor Response Evaluation

Who this might be right for
Hepatocellular CancerMetastatic Liver Cancer
The University of Texas Health Science Center, Houston 10
Not applicableUnknownNCT05183425
What this trial is testing

Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis

Who this might be right for
Explore the Consistency of Drug Sensitivity Between Primary Colorectal Cancer and Liver Metastases
Changhai Hospital 60
Not applicableLooking for participantsNCT06698146
What this trial is testing

Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection

Who this might be right for
Liver Transplant SurgeryColorectal Cancer MetastaticColon Cancer Liver Metastases
Northwestern University 80
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Early research (Phase 1)Ended earlyNCT02559024
What this trial is testing

Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Providence Health & Services 4
Not applicableLooking for participantsNCT06701968
What this trial is testing

Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease

Who this might be right for
Coronary DiseaseCoronary ArteriosclerosisMyocardial Infarction+3 more
Uppsala University 150
Not applicableStudy completedNCT00899210
What this trial is testing

Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University Hospital, Grenoble 75
Large-scale testing (Phase 3)Ended earlyNCT01121601
What this trial is testing

CoSeal in Liver and Biliary Surgery in Prevention of Denovo Hepatic Adhesion

Who this might be right for
Patient With Hepatic Metastasis
Centre Hospitalier Universitaire de Besancon 29
Not applicableLooking for participantsNCT06227728
What this trial is testing

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Who this might be right for
Non Small Cell Lung CancerBreast CancerColorectal Cancer+4 more
Gene Solutions 50
Not applicableNot Yet RecruitingNCT07564284
What this trial is testing

Liver-First, Bowel-First, or Simultaneous Resection for Synchronous Colorectal Liver Metastases: Outcomes, Quality of Life, and Cost-Effectiveness

Who this might be right for
Liver Metastases From Colorectal Cancer
Karolinska Institutet 200
Testing effectiveness (Phase 2)Looking for participantsNCT06555133
What this trial is testing

Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

Who this might be right for
Colorectal Carcinoma Metastatic in the Liver
Brown University 18
Testing effectiveness (Phase 2)Study completedNCT00103298
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00005616
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05822752
What this trial is testing

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
AbbVie 130
Next Page